WASHINGTON, June 14 /PRNewswire/ -- The Biotechnology Industry
Organization (BIO) today announced "Converging Sciences," a two-day track of
symposia scheduled for June 26-27 during BIO 2001, on the convergence of
biotechnology and information technology.
The speed with which biotechnology companies can bring life-saving drugs
and therapies to patients who need them depends greatly on swift and precise
product discovery and development as well as prompt and effective review by
regulatory authorities (U.S. Food and Drug Administration). According to BIO,
the adoption of innovative electronic information technology by biotech
companies can be a major catalyst for both processes.
On June 26, BIO 2001 attendees will hear high-tech industry leaders
discuss data mining, knowledge management, collaboration and process
management in a symposium entitled "e-Solutions for the Life Sciences."
On June 27, FDA officials will participate in "The Emergence of the
Electronic FDA." Conference attendees will hear about the latest FDA
initiatives on regulatory information access and automated processes. The
symposium will also cover Internet-based electronic and computerized
submissions, including practical case studies.
Major sponsors of "Converging Sciences" include Accenture, BioQ, IBM and
Sun Microsystems. These companies will offer speakers and comprehensive
exhibits tailored to the needs of the life sciences industry.
Accenture's Pharmaceuticals & Medical Products professionals work with
over 90 percent of Fortune's Global 500 pharmaceutical companies to create
value in areas such as strategy development, research and development,
finance, manufacturing, logistics, information technology, marketing and
sales, and human resources.
Accenture is the world's leading provider of management and technology
consulting services and solutions, with more than 70,000 people in 46
countries delivering a wide range of specialized capabilities and solutions to
clients across all industries. Accenture operates globally with one common
brand and business model designed to enable the company to serve its clients
on a consistent basis around the world. Under its strategy, Accenture is
building a network of businesses to meet the full range of any organization's
needs -- consulting, technology, outsourcing, alliances and venture capital.
The company generated revenues of $9.75 billion for the fiscal year ended
August 31, 2000 and $5.71 billion for the six months ended February 28, 2001.
Its home page is http://www.accenture.com .
BioQ is a San Diego area software company that has information technology
specifically targeted to access regulatory information and imbed institutional
knowledge management within the drug development process.
IBM is currently helping biotech and pharmaceutical research and
development organizations optimize information technology to accelerate the
development of new medical treatments. IBM Life Sciences brings together IBM
resources, from research and e-business expertise to data and storage
management and high-performance computing, to offer new solutions for the life
sciences market, including biotechnology, genomic, e-health, pharmaceutical,
and agri-science industries. IBM Life Sciences has announced several key
strategic partnerships with leading life sciences companies, and is
participating in the Interoperable Informatics Infrastructure Consortium
(I3C).
Sun Microsystems will describe how they are helping to drive convergence
across IT in life sciences through collaboration. They have already launched
several programs including their Discovery Informatics & Life Sciences Program
to help empower their partners; their Informatics Advisory Council to better
understand the needs of the life sciences community; and helped establish the
Interoperable Informatics Infrastructure Consortium (I3C). Their IT expertise
is now being applied across the whole value chain of life sciences, from
discovery all the way through to sales, marketing, and CRM.
BIO represents more than 950 biotechnology companies, academic
institutions, state biotechnology centers and related organizations in all 50
U.S. states and 33 other nations. BIO members are involved in the research
and development of health-care, agricultural, industrial and environmental
biotechnology products.
The organization is hosting BIO 2001, the world's largest biotechnology
event in San Diego, CA, June 24-27. More than 12,000 biotechnology industry
leaders and executives from around the world are expected to gather,
showcasing the latest advances in health care, agricultural, industrial and
environmental management. BIO offers three days of business development and
scientific sessions, ranging from "Creative Partnering Models for
Pharmaceutical and Biotechnology Companies" to "Genomics in the Information
Age." For more information, visit http://www.bio2001.org .
SOURCE Biotechnology Industry Organization (BIO)
 back to top
Related links:
http://www.accenture.com
http://www.bio.org http://www.bio2001.org
CONTACT:
Dan Eramian of BIO, 202-857-0244
|
